Bayer and Tsinghua University sign the sixth phase of research strategic cooperation agreement.

On June 24th, Bayer and Tsinghua University signed the sixth phase of their research strategic cooperation agreement, further supporting the transformation of basic research results in key areas such as oncology, cardiovascular and renal diseases, neurology, rare diseases, and immunology into new drug development. According to the cooperation agreement, Bayer will continue to fund joint research projects between both parties in the next three years, and provide incentives to Tsinghua University scientists who have made outstanding research contributions in the fields of life sciences and pharmaceutical innovation.